新希望(000876.SZ)擬向控股股東申請不超10億元借款
格隆匯3月5日丨新希望(000876.SZ)公佈,公司有10億的防疫專項款,是隨公司的控股股東新希望集團有限公司(以下簡稱“新希望集團”)申請,並已進入了全國性防疫重點保障企業名單,根據財金[2020]3號文件及防疫專項貸款相關指導意見,公司隨控股股東申請的10億防疫專項貸款,需要由金融機構,按防疫專項優惠利率貸款給控股股東,再由控股股東按同利率再貸款給公司,由公司按防疫專項貸款的相關規定,專款用於防疫保供背景下的生產經營和發展,以保障人民的肉類生活需求。公司特此向新希望集團借款,實現向金融機構申請獲取不超過10億元人民幣專項防疫貸款,並由新希望集團幫助公司申請相關貼息。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.